Welcome back to another edition of Endpoints Weekly! We’ll get to the headlines in just a bit, but be sure to check out the ...
Endpoints takes its China biotech debate to DC: four Post-Hoc Live conversations on patents, FDA data, biosecurity and ...
Legend Biotech has tapped Novartis executive Ingrid Zhang as its new CEO at a time when the company is seeking its next act.
All 50 states, DC and Puerto Rico join CMS' Generous model, tying Medicaid drug prices to what other wealthy countries pay.
The FDA approved a new combination regimen from Eli Lilly for certain breast cancer patients, a regimen that includes Lilly’s oral selective estrogen receptor degrader (SERD) ...
China's new five-year plan targets 20% annual pharma revenue growth and a quarter of the world's first-in-class drugs by 2030 ...
An FDA report pushes back on claims it's rejecting more drugs, showing first-cycle rejection rates fell from 47% in 2008 to about 27% in 2024.
Anthropic launched a Life Sciences Verification Program, granting select researchers access to AI models Mythos, Opus, and Sonnet, while maintaining biosafety restrictions on high-risk biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results